CompletedPhase 3NCT03271918

Cabergoline in Nonfunctioning Pituitary Adenomas

Studying Non-functioning pituitary adenoma

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Sao Paulo General Hospital
Principal Investigator: Rafael L Batista, MD
Instituto do Coracao
Intervention: Cabergoline(drug)
Enrollment: 140 enrolled
Eligibility: 18-75 years · All sexes
Timeline: 2015 – 2017

Study locations (1)

Laboratorio de Investigacoes Medicas 25, São Paulo, São Paulo, Brazil

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03271918 on ClinicalTrials.gov

Other trials for Non-functioning pituitary adenoma

Additional recruiting or active studies for the same condition.

ENROLLING BY INVITATIONPHASE4NCT07034859
Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
National Taiwan University Hospital

See all trials for Non-functioning pituitary adenoma →

← Back to all trials